Showing results (21-30 of 644) with videos related to
Sort By:
Pageof 65
Seminars in Surgical Oncology|December 18, 2001
Minimal residual disease in non-small-cell lung cancerS B Hosch, P Scheunemann, J R IzbickiRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2010
Current diagnosis and future impact of micrometastases for therapeutic strategies in adenocarcinoma of the esophagus, gastric cardia, and upper gastric thirdAsad Kutup, Emre F Yekebas, Jakob R IzbickiDigestive Surgery|July 12, 2017
Does the Margin Matter in Esophageal CancerKarl-Frederick Karstens, Jakob R Izbicki, Matthias ReehZentralblatt Fur Chirurgie|January 1, 1989
[Surgical treatment of malignant tumors of the appendix]J R Izbicki, E Eypasch, R Seel, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 31, 2008
Chronic pancreatitis--a surgeons' viewKai Bachmann, Oliver Mann, Jakob R Izbicki, et al.Surgery Today|August 27, 1998
Postoperative infection after transsternal thymectomy for myasthenia gravis: a retrospective analysis of 125 casesA Machens, T Emskötter, C Busch, et al.Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|January 1, 1996
[Limits of surgery in patients with apparently localized bronchial carcinoma (pT1-3, pN0, M0)]B Passlick, O Thetter, K Pantel, et al.Langenbeck'S Archives of Surgery|April 25, 2003
Molecular markers and staging of early esophageal cancerStefan B Hosch, Nikolas H Stoecklein, Jakob R IzbickiAnnali Italiani Di Chirurgia|June 1, 2000
Modifications of the duodenum-preserving pancreatic head resectionT Strate, C Bloechle, C Busch, et al.Expert Opinion on Therapeutic Targets|September 27, 2014
The potential for targeting HER2 therapeutically in esophageal cancer - a grasp at straws?Faik G Uzunoglu, Alexandra M Koenig, Jakob R IzbickiPageof 65